What is myopia?
With myopia, also called nearsightedness, people have trouble seeing at a distance. If there is a family history of nearsightedness, it is more likely to occur in children. Most kids aren’t aware that they don’t see well, and the effect poor vision has on development can be significant. Children with myopia often struggle in school and with other activities due to poor vision and have an increased risk of eye disease.
Childhood myopia is typically diagnosed between the ages of five and seven. Often vision continues to get worse every year and then levels off in the late teen years.
Why aren’t glasses good enough?
Glasses and contact lenses can provide effective correction, but they do not address the underlying condition, and vision continues to worsen as children get older. Up to 15% of myopic patients will become highly myopic, which leads to an increased risk of glaucoma, retinal detachment and abnormal blood vessel growth beneath the retina.
At this time, myopia can’t be stopped, but it could possibly be slowed. There are now non-surgical treatments that aim to manage myopia by slowing down progression in children’s actively growing eyes.
What does the treatment involve?
The typical treatment for myopia is wearing glasses, with frequent prescription updates as the vision gets worse. Studies, such as Atropine for the Treatment of Myopia (ATOM 1 and 2) and LAMP, have shown that a low dose of atropine, given to children as an eye drop at bedtime, can slow the progression of myopia.
Myopia is not reversible, and glasses will still be needed, but in many cases with atropine treatment the progression slows by about one-half.
What are the results?
The World Society of Pediatric Ophthalmology and Strabismus has concluded that “Atropine 0.01% dose appears to offer an appropriate risk-benefit ratio, with no clinically significant visual side effects balanced against a reasonable and clinically significant 50% reduction in myopia progression.”
Atropine has been used to dilate the pupil and treat lazy eye in children for many years and is not a new medication. Overall the safety of low dose atropine has been extremely good with no evidence to suggest that there are long-term side effects. Drop use may cause slightly dilated pupils and reduced accommodation (focus at near). Both revert to normal when treatment is completed. Some children may be poor responders to atropine. Some may be allergic. Younger children and those with greater myopic progression are more likely to require re-treatment. Please discuss any concerns with the doctor.
What’s your next step?
If the doctor thinks your child would be a good candidate for treatment, a consult will be scheduled for measurements and education. At that appointment, a prescription for Atropine may be authorized. You will be placed in contact with a pharmacy to order and pay for the prescription, which will be shipped directly to your home. Another appointment will be scheduled with your child’s eye doctor at six months to measure the effectiveness. Treatment is typically for one year but may be extended annually depending on results.